Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis

Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis

Aim. To determine biomarkers of anemia of chronic disease (ACD) in patients with glomerulonephritis (GN) in the early stages of CKD, to assess their role as risk factors for cardiovascular complications (CVС). Materials and methods. Seventy nine patients with GN were studied, among them: 40 with...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marina V. Markina, Ludmila Yu. Milovanova, Lidia V. Lysenko, Svetlana Yu. Milovanova, Alexey V. Volkov, Vladimir D. Beketov, Marina V. Lebedeva, Kirill S. Nezhdanov, Sergey V. Moiseev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2024-01-01
Series:	Терапевтический архив
Subjects:	аnemia of chronic diseases chronic kidney disease glomerulonephritis in systemic diseases klotho
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/634096/149182
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE STUDY OF SELF-ATTITUDE OF YOUNGER ADOLESCENTS WITH CHRONIC DISEASES (CASE STUDY OF PATIENTS WITH CHRONIC GLOMERULONEPHRITIS)
by: T. V. Sviridova, et al.
Published: (2013-09-01)

Modern approaches to the chronic glomerulonephritis classification
by: Irina N. Bobkova, et al.
Published: (2025-01-01)

Gut microbiota: Historical essay and role in nephrology
by: Kirill S. Nezhdanov, et al.
Published: (2025-01-01)

Pregnancy complications and gestational proteinuria and serum creatinine dynamics in women with chronic glomerulonephritis and chronic tubulointerstitial kidney diseases
by: E. I. Prokopenko, et al.
Published: (2025-05-01)

The importance of whey protein levels of Klotho and fibroblast growth of factor-23 (fgf-23) as early diagnostic markers of chronic kidney damage
by: L. Yu. Milovanova, et al.
Published: (2014-06-01)

THE CLINICAL SIGNIFICANCE OF THE DAILY MONITORING OF HOLTER ECG IN CHRONIC GLOMERULONEPHRITIS AT THE PREDIALYSIS STAGE OF THE DISEASE
by: I. T. Murkamilov, et al.
Published: (2019-02-01)

Оrganoprotective efficiency of eprosartan in patients with chronic glomerulonephritis
by: Ye. V. Kalyuzhina, et al.
Published: (2007-03-01)

Research progress on the biological role of serum soluble α-Klotho in chronic kidney diseases
by: SUN Long, et al.
Published: (2020-01-01)

Clinical efficacy of benazepril and irbesartan for children with chronic glomerulonephritis
by: LIU Xiao-yan
Published: (2016-01-01)

Predictive factors of progression to chronic glomerulonephritis in pediatric patients with post streptococcal acute glomerulonephritis
by: Ida Ayu Laksmi Arnita Utari, et al.
Published: (2024-11-01)

IMMUNOLOGICAL REACTIVITY IN CHILDREN WITH CHRONIC GLOMERULONEPHRITIS
by: R. O. Beglarov
Published: (2018-03-01)

SUBCLINICAL LESION OF CAROTID ARTERIES IN CHRONIC GLOMERULONEPHRITIS
by: I. T. Murkamilov, et al.
Published: (2017-08-01)

Analysis of Klotho Protein Level in Patients with Myocardial Infarction and Concurrent Chronic Obstructive Pulmonary Disease with Different Manifestations
by: E. V. Kespleri, et al.
Published: (2021-09-01)

Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib
by: Rafeea Shah, et al.
Published: (2024-10-01)

Hypertension modifies the association between serum Klotho and chronic kidney disease in US adults with diabetes: a cross-sectional study of the NHANES 2007–2016
by: Tao Hong, et al.
Published: (2025-12-01)

Prevalence of anemia in patients with type 1 and type 2 diabetes mellitus with chronic renal disease
by: Sergey A. Martynov, et al.
Published: (2017-12-01)

Expression of DKK3 in chronic glomerulonephritis tissues and its induction of migration of glomerular podocytes
by: XU Wei-jia, et al.
Published: (2019-01-01)

Serum alpha-klotho levels associate with bone mineral density in chronic kidney disease patients from NHANES 2011 to 2016
by: Yani Zhang, et al.
Published: (2025-05-01)

Role of remodeling of small diameter kidney arteries in the prognosis of progression of tubulointerstitial fibrosis in patients with chronic glomerulonephritis
by: E. S. Levitskaya, et al.
Published: (2019-06-01)

Arterial hypertension as a heart failure predictor in patients with chronic glomerulonephritis and intact renal function
by: N. Yu. Borovkova, et al.
Published: (2009-10-01)

Inflammation-Induced Klotho Deficiency: A Possible Key Driver of Chronic Kidney Disease Progression
by: Liang Y, et al.
Published: (2025-05-01)

Nonlinear relationship between serum Klotho and chronic kidney disease in US adults with metabolic syndrome
by: Xiaobin Lin, et al.
Published: (2024-12-01)

Anemia of chronic disease
by: V. Yu. Pavlova, et al.
Published: (2021-07-01)

Factors associated with the outcomes of ANCA-associated glomerulonephritis: a retrospective cohort study
by: Nikolay M. Bulanov, et al.
Published: (2025-01-01)

Effect of self-management support on the progression of primary chronic glomerulonephritis
by: QIN Xin-dong, et al.
Published: (2015-01-01)

Prediction of small-diameter arterial fibrosis in patients with hypertension and primary chronic glomerulonephritis
by: E. S. Levitskaya, et al.
Published: (2020-07-01)

Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021
by: Lanhui Wang, et al.
Published: (2025-07-01)

The influence of renal anemia on cardiac remodelling in chronic glomerulonephritis
by: I. T. Murkamilov, et al.
Published: (2016-10-01)

Correction: Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021
by: Lanhui Wang, et al.
Published: (2025-08-01)

The association between low-concentration heavy metal exposure and chronic kidney disease risk through α-klotho
by: Sishi Liu, et al.
Published: (2025-04-01)

Integrating proteomics and network pharmacology to explore the relevant mechanism of Huangkui capsule in the treatment of chronic glomerulonephritis
by: Chang Qing Wen, et al.
Published: (2025-04-01)

Prevention of chronic kidney disease progression in patients with acute decompensation of chronic heart failure
by: V. V. Davydov, et al.
Published: (2019-04-01)

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)

Spectrum of renal diseases in the pediatric population of Nepal
by: Nirajan Mainali, et al.
Published: (2024-10-01)

CHRONIC OBSTRUCTIVE LUNG DISEASE AS RISK FACTOR FOR CARDIOVASCULAR DISORDERS
by: A. V. Budnevsky, et al.
Published: (2016-06-01)

Chronic hepatitis B and risk of kidney involvement
by: M. V. Mayevskaya, et al.
Published: (2013-05-01)

LYMPHOPENIA AS A FACTOR INVOLVED IN THE AUTOIMMUNITY DEVELOPMENT IN MURINE GRAFT VS. HOST DISEASE
by: E. V. Goiman, et al.
Published: (2012-05-01)

Case report: in focus IgA nephropathy as a gluten-related disorder
by: M. E. Mantsaeva, et al.
Published: (2021-07-01)

Reversibility of chronic heart failure symptoms in chronic kidney disease patients
by: V. V. Belov, et al.
Published: (2007-02-01)

Effects of soluble Klotho and Wnt/β-catenin signaling pathway in vascular calcification in chronic kidney disease model rats and the intervention of Shenyuan granules
by: Xinrong Zou, et al.
Published: (2024-12-01)